G1/S transition

Definition

The G1/S transition is a crucial checkpoint in the cell cycle where a cell decides whether to proceed with division or enter a resting phase. This transition is significant because it assesses the cell's size, DNA integrity, and environmental conditions, ensuring that only healthy cells continue to replicate. This decision-making process directly impacts growth and development, and its disruption is often linked to cancer progression.

5 Must Know Facts For Your Next Test

1. The G1/S transition is influenced by various factors including growth factors, nutrients, and DNA damage signals.
2. Cyclin D and cyclin E play essential roles in regulating the G1/S transition by activating CDKs that phosphorylate target proteins.
3. If a cell fails the G1/S checkpoint due to DNA damage or inadequate size, it can either repair the damage or enter a resting state known as G0 phase.
4. Cancer cells often bypass the G1/S transition checkpoint, allowing them to proliferate uncontrollably even in unfavorable conditions.
5. The p53 protein is a critical regulator at the G1/S checkpoint; its activation leads to cell cycle arrest or apoptosis in response to DNA damage.

Review Questions

• How does the G1/S transition checkpoint help maintain cellular integrity?
  • The G1/S transition checkpoint serves as a critical point for assessing whether a cell is ready to divide. It evaluates the cell's size, nutrient availability, and DNA integrity. By ensuring that only cells that meet these criteria proceed to DNA replication, this checkpoint helps prevent damaged or incomplete cells from undergoing division, thereby maintaining cellular integrity and preventing potential cancerous growth.
• Discuss the role of cyclins and CDKs in regulating the G1/S transition and how their dysregulation can lead to cancer.
  • Cyclins, particularly cyclin D and cyclin E, bind to cyclin-dependent kinases (CDKs) to form active complexes that drive the cell through the G1/S transition. These complexes phosphorylate key proteins necessary for progression into the S phase. Dysregulation of this process, such as overexpression of cyclins or mutations in CDKs, can lead to unregulated cell division and contribute to tumorigenesis by allowing cells with damaged DNA to continue replicating.
• Evaluate how disruptions in the G1/S transition contribute to cancer development and what therapeutic approaches could target this pathway.
  • Disruptions in the G1/S transition can lead to uncontrolled cell proliferation, a hallmark of cancer. Mutations in genes responsible for regulating this checkpoint, such as those affecting p53 or cyclins/CDKs, allow damaged cells to bypass crucial assessments before DNA replication. Therapeutic approaches targeting this pathway may include inhibitors that specifically block CDK activity or restore function to tumor suppressor genes like p53, thus re-establishing control over cell cycle progression and limiting cancer growth.

Related terms

Cell Cycle: The series of phases that a cell goes through as it grows and divides, consisting of interphase (G1, S, G2) and mitotic phase (M).

Cyclins:

Regulatory proteins that control the progression of cells through the cell cycle by activating cyclin-dependent kinases (CDKs).

Tumor Suppressor Genes: Genes that encode proteins which help prevent uncontrolled cell growth; mutations in these genes can lead to cancer.